Thank you very much, Mr. Chairman. Thank you, Ranking Member. I am glad you're having this hearing.

People count on us to put laws in place that will protect our citizens from this sort of harm.

Less than a quarter of the State boards provide inspectors any training to detect problems with sterile compounding.

I think we have a different response here.

I just want to say I think it's unconscionable that we have failed to regulate this industry for so long and put the public at risk.

I feel a special duty to ensure that we do everything possible to protect people from unsafe drugs.

We've done subsequent inspections and found that there continue to be--even after this tragedy, even after all the heightened awareness, there continue to be substantial violations of the basic rules of keeping these products clean and…

No State boards of pharmacy require the pharmacies to disclose the amount of drug they are compounding or whether they're sold across State lines.

But, basically, the compounding industry doesn't tell, and as long as they don't tell, we don't have the kind of public scrutiny that causes us to move forward with this kind of legislation.

The current state of our oversight of the compounding industry is outdated and inadequate.

So you're telling me that we really have some serious gaps there, potentially.